Improving the identification of frail elderly newly diagnosed multiple myeloma patients
Author:
Funder
Janssen Pharmaceuticals
KWF Kankerbestrijding
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
https://www.nature.com/articles/s41375-021-01162-z.pdf
Reference15 articles.
1. Salazar AS, Recinos LM, Mian HS, Stoll C, Simon LE, Sekhon S, et al. Geriatric assessment and frailty scores predict mortality in myeloma: systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2019;19:488–96 e486.
2. Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125:2068–74.
3. Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, Wasch R, et al. Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score. Blood Cancer J. 2011;1:e35.
4. Gavriatopoulou M, Fotiou D, Koloventzou U, Roussou M, Migkou M, Ntanasis-Stathopoulos I, et al. Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients. Leuk Lymphoma. 2019;60:619–28.
5. Mina R, Bringhen S, Wildes TM, Zweegman S, Rosko AE. Approach to the older adult with multiple myeloma. ASCO Educ Book. 2019;39:500–18.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic frailty-based determinants of long-term mortality in older patients with newly diagnosed multiple myeloma;2024-08-20
2. Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma;2024-05-15
3. New Strategies for the Treatment of Older Myeloma Patients;Cancers;2023-05-10
4. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review;Blood Cancer Journal;2023-01-05
5. An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence;Haematologica;2022-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3